Pfizer Inc (PFE)

$25.86 +0.20 (0.78%)
Market Cap 144.37B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.28
Forward PE 8.48
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 24,245,332
Avg Vol 37,744,758
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 31%
Beta 0.35
Analysts Sell
Price Target $29.28

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
morgangj
morgangj May. 20 at 7:41 PM
$PFE
0 · Reply
Skyhigh_69
Skyhigh_69 May. 20 at 7:36 PM
$PFE Looking to good to be true here.
1 · Reply
pasuny
pasuny May. 20 at 6:15 PM
$PFE Seriously, the CEO really needs to step down! What options do we, as shareholders, have?
1 · Reply
pasuny
pasuny May. 20 at 6:12 PM
$PFE miserable worthless pathetic disgusting filthy piece of sxxt
0 · Reply
biolover
biolover May. 20 at 6:06 PM
$VKTX timing is not as important as molecules qualities. $PFE is screwed up in obesity long term.
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 20 at 6:05 PM
$PFE god I can’t stand this stocks movement
0 · Reply
GreenEnergy7B
GreenEnergy7B May. 20 at 5:46 PM
$ALT GLP1 / FGF21 MASH, VCTE Drug comparison $PFE $MRK $NVO $LLY
0 · Reply
Skyhigh_69
Skyhigh_69 May. 20 at 5:26 PM
$PFE Get ready for consecutive green days ahead. I know this price action like the back of my hand. We have a confirmed reversal folks.
2 · Reply
pasuny
pasuny May. 20 at 5:26 PM
$PFE Everybody's flipping out when this garbage goes up 1% how pathetic lol
0 · Reply
Skyhigh_69
Skyhigh_69 May. 20 at 5:22 PM
$PFE Folks we're going higher.
0 · Reply
Latest News on PFE
Moderately bullish activity in Pfizer with shares up 0.41%

2026-05-20T17:00:11.000Z - 2 hours ago

Moderately bullish activity in Pfizer with shares up 0.41%

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 9:00 AM EDT - 6 hours ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

Pfizer announces pneumococcal conjugate vaccine candidate data

2026-05-20T09:30:10.000Z - 10 hours ago

Pfizer announces pneumococcal conjugate vaccine candidate data

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:08 AM EDT - 10 hours ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

May 20, 2026, 5:05 AM EDT - 10 hours ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

2026-05-18T17:01:06.000Z - 2 days ago

PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

AZN LLY NVO SNY

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 18, 2026, 8:00 AM EDT - 2 days ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

May 14, 2026, 2:22 PM EDT - 6 days ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-14T17:29:38.000Z - 6 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research

Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:23:39.000Z - 7 days ago

Mixed options sentiment in Pfizer with shares up 0.48%

Arvinas price target raised to $16 from $14 at BofA

2026-05-13T19:22:15.000Z - 7 days ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL

Pfizer says EC grants marketing approval to expand indication for Hympavzi

2026-05-13T11:10:14.000Z - 7 days ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 7 days ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

2026-05-13T07:12:25.000Z - 7 days ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

2026-05-12T17:45:03.000Z - 8 days ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

ARVN RIGL

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

2026-05-12T16:35:26.000Z - 8 days ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

ARVN RIGL

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

2026-05-12T13:02:04.000Z - 8 days ago

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

ARVN RIGL

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 8 days ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 8 days ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 14 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 14 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 15 days ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 15 days ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 15 days ago

Pfizer Earnings release: Q1 2026

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 15 days ago

Pfizer Quarterly report: Q1 2026

Pfizer Slides: Q1 2026

May 5, 2026, 10:00 AM EDT - 15 days ago

Pfizer Slides: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 15 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 15 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 15 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 15 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 15 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 15 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 15 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 19 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 21 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 21 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 22 days ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 22 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 26 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 27 days ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 27 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 4 weeks ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 4 weeks ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 4 weeks ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 4 weeks ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 4 weeks ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 5 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 6 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 7 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 7 weeks ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 7 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 2 months ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 2 months ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 2 months ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 2 months ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 2 months ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 2 months ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 2 months ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 2 months ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 2 months ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 2 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 2 months ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Pfizer Proxy statement: Proxy Filing

Pfizer Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Pfizer Proxy statement: Proxy Filing

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 2 months ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

morgangj
morgangj May. 20 at 7:41 PM
$PFE
0 · Reply
Skyhigh_69
Skyhigh_69 May. 20 at 7:36 PM
$PFE Looking to good to be true here.
1 · Reply
pasuny
pasuny May. 20 at 6:15 PM
$PFE Seriously, the CEO really needs to step down! What options do we, as shareholders, have?
1 · Reply
pasuny
pasuny May. 20 at 6:12 PM
$PFE miserable worthless pathetic disgusting filthy piece of sxxt
0 · Reply
biolover
biolover May. 20 at 6:06 PM
$VKTX timing is not as important as molecules qualities. $PFE is screwed up in obesity long term.
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 20 at 6:05 PM
$PFE god I can’t stand this stocks movement
0 · Reply
GreenEnergy7B
GreenEnergy7B May. 20 at 5:46 PM
$ALT GLP1 / FGF21 MASH, VCTE Drug comparison $PFE $MRK $NVO $LLY
0 · Reply
Skyhigh_69
Skyhigh_69 May. 20 at 5:26 PM
$PFE Get ready for consecutive green days ahead. I know this price action like the back of my hand. We have a confirmed reversal folks.
2 · Reply
pasuny
pasuny May. 20 at 5:26 PM
$PFE Everybody's flipping out when this garbage goes up 1% how pathetic lol
0 · Reply
Skyhigh_69
Skyhigh_69 May. 20 at 5:22 PM
$PFE Folks we're going higher.
0 · Reply
Sabby_Management
Sabby_Management May. 20 at 4:56 PM
$PFE this is probably the easiest swing trade for a whopping .5% gain per day.
0 · Reply
dust6431
dust6431 May. 20 at 4:27 PM
$PFE mofos checking price
0 · Reply
OptionRunners
OptionRunners May. 20 at 4:03 PM
I'm long $PFE back to its long term weekly uptrend support and following this August flow
0 · Reply
pasuny
pasuny May. 20 at 4:02 PM
$PFE Stupid filthy piece of crap. Pathetic miserable worthless company.
0 · Reply
NEWBIGTECH
NEWBIGTECH May. 20 at 3:57 PM
$SLS $ABBV $PFE
0 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 20 at 3:50 PM
$SLS Phase 3 Registrational Results giving Gps the Fda green light to treat 100,000 AML Patients, currently in remission + 40/50,000 more each year - are Coming. - could be any day now. $28B TAM just for AML is worth every nickel of $40B to Big Pharma $ABBV $PFE
0 · Reply
Mrdrifter
Mrdrifter May. 20 at 3:48 PM
$PFE
0 · Reply
9ForMyLostGod
9ForMyLostGod May. 20 at 3:35 PM
$SPHD Just bought this yesterday to complement my holdings in $PEY and $DIV. Nice divvy, and not too much crossover except for $MO and $PFE
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 20 at 3:26 PM
$PFE yeah.. Go red
0 · Reply
F_I_R_E_
F_I_R_E_ May. 20 at 3:18 PM
$PFE $NVO will be the same price +/- $5 10 years from now
0 · Reply
reyofhope
reyofhope May. 20 at 3:17 PM
$PFE what's cooking is some Greek food by big Al get ready for the OPA dance. I'm holding.
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 20 at 3:09 PM
$PFE every single time
0 · Reply